4-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-AMINE, 97.0%, 1g

Methyl 4-(Bromomethyl)-3-methoxybenzoate>97.0%(GC)25g

1-(4-Methylphenyl)cyclopropanecarboxylic acid, 97.0%, 100g

4-Bromo-5-fluoro-1-methylpyridin-2(1H)-one, 97%, 50mg

Methyl 4-acetamido-5-iodo-2-methoxybenzoate, 95.0%, 500mg

GC capillary column ROTI®Cap-1, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)

(S)-(-)-1-(4-Methoxyphenyl)ethylamine>98.0%(GC)(T)5g

1,6-diiodohexane, 98.0%, 500g

4-(Morpholine-4-sulfonyl)-aniline, 95.0%, 100g

1-(5-Bromo-2-nitro-phenyl)ethanone, 98.0%, 1g

3-Phenylpropylisothiocyanate, 99.0%, 5g

2-Fluoro-6-(pyrrolidin-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 5g

3,4-Dimethoxyphenylacetic acid hydrazide, 95.0%, 100g